Catalyst Wire Dossier Catalyst Wire Dossier

NAGLAZYME

GALSULFASE · BioMarin Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for NAGLAZYME, covering 2009-08-25 to 2024-12-16. Get the full timeline:

Most recent: EMA Authorised: Naglazyme (galsulfase) — BioMarin International Limited

See pricing